Sumitomo Pharma Am Drug Patent Portfolio
Sumitomo Pharma Am's Family Patents
Clinical Trials
Recent Clinical Trials by Sumitomo Pharma Am:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate | Sumitomo Pharma America, Inc. | NA |
COMPLETED
(Jun 1, 2026)
| PHASE3 |
| A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) | Sumitomo Pharma America, Inc. | NA |
RECRUITING
(Mar 1, 2026)
| PHASE1, PHASE2 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List